OR WAIT null SECS
May 15, 2020
Ensuring the quality of data in process monitoring and control systems starts in process development phases.
Regulators have exaggerated expectations for simulated media fills.
May 02, 2020
Experience, communication, collaboration, transparency, planning, and prioritization contribute to success.
Bioprocessing advances improve product yield, cut costs, and streamline integration between upstream and downstream processes.
The CuDAL-Excel program, based on Microsoft (MS) Excel, has been developed to calculate the United States Pharmacopeia (USP) passing probability of content uniformity and dissolution tests for both sampling plan 1 and sampling plan 2 scenarios and for both immediate release and extended release requirements. The users can obtain the passing probability by simply entering the input variables, with wide applications for process validation/verification and batch release. As a user-friendly program, CuDAL‑Excel should bring more benefits to the industry practitioners than other existing programs/tools.
April 22, 2020
Analyzing process and equipment data provides insights that can improve quality and productivity of pharmaceutical manufacturing.
April 16, 2020
The technology center is dedicated to developing greener, safer chemistries for manufacturing pharmaceutical raw materials and intermediates.
April 02, 2020
Because conventional cleaning methods can risk product loss, biopharmaceutical manufacturers are often reluctant to use PDE/ADE limits to validate cleaning processes.
April 01, 2020
The new patented process results in uniform, scalable production and the ability to deliver cell cargo similar to natural exosomes/extracellular vesicles.
March 02, 2020
Tackling process development early on can better optimize manufacturing processes for emerging therapies.